loadpatents
name:-0.077178001403809
name:-0.059912919998169
name:-0.0030820369720459
Bohlmann; Rolf Patent Filings

Bohlmann; Rolf

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bohlmann; Rolf.The latest application filed is for "substituted dihydroimidazopyridinediones as mknk1 and mknk2 inhibitors".

Company Profile
2.62.76
  • Bohlmann; Rolf - Berlin DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitors
Grant 11,311,520 - Klar , et al. April 26, 2
2022-04-26
Substituted Dihydroimidazopyridinediones As Mknk1 And Mknk2 Inhibitors
App 20210085656 - KLAR; Ulrich ;   et al.
2021-03-25
Substituted Dihydroimidazopyridinediones As Mknk1 And Mknk2 Inhibitors
App 20190350910 - KLAR; Ulrich ;   et al.
2019-11-21
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
Grant 9,962,389 - Lucking , et al. May 8, 2
2018-05-08
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Grant 9,877,954 - Lucking , et al. January 30, 2
2018-01-30
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
Grant 9,790,189 - Lucking , et al. October 17, 2
2017-10-17
4-aryl-n-phenyl-1,3,5-triazin-2-amines Containing A Sulfoximine Group
App 20170217949 - LUCKING; Ulrich ;   et al.
2017-08-03
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine Derivatives Containing A Sulfoximine Group
App 20170202815 - LUCKING; Ulrich ;   et al.
2017-07-20
N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
Grant 9,708,293 - Lucking , et al. July 18, 2
2017-07-18
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
Grant 9,670,161 - Lucking , et al. June 6, 2
2017-06-06
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
Grant 9,669,034 - Lucking , et al. June 6, 2
2017-06-06
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Grant 9,650,340 - Lucking , et al. May 16, 2
2017-05-16
N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group
Grant 9,650,361 - Lucking , et al. May 16, 2
2017-05-16
Disubstituted 5-fluoro Pyrimidine Derivatives Containing A Sulfondiimine Group
App 20170015634 - LUCKING; Ulrich ;   et al.
2017-01-19
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
Grant 9,499,492 - Lucking , et al. November 22, 2
2016-11-22
Imidazopyrazines
Grant 9,468,642 - Klar , et al. October 18, 2
2016-10-18
Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors
Grant 9,284,317 - Koppitz , et al. March 15, 2
2016-03-15
Substituted imidazopyridazines
Grant 9,255,100 - Klar , et al. February 9, 2
2016-02-09
6-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitors
Grant 9,212,184 - Koppitz , et al. December 15, 2
2015-12-15
Substituted imidazopyrazines
Grant 9,199,999 - Klar , et al. December 1, 2
2015-12-01
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl Amines Containing A Sulfoximine Group
App 20150291537 - Lucking; Ulrich ;   et al.
2015-10-15
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine Derivatives Containing A Sulfoximine Group
App 20150291528 - Lucking; Ulrich ;   et al.
2015-10-15
N-(pyridin-2-yl)pyrimidin-4-amine Derivatives Containing A Sulfoximine Group
App 20150291559 - Lucking; Ulrich ;   et al.
2015-10-15
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine Derivatives Containing A Sulfone Group
App 20150274666 - Lucking; Ulrich ;   et al.
2015-10-01
N-(pyridin-2-yl)pyrimidin-4-amine Derivatives Containing A Sulfone Group
App 20150274695 - Lucking; Ulrich ;   et al.
2015-10-01
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl Amines Containing A Sulfone Group
App 20150259300 - Lucking; Ulrich ;   et al.
2015-09-17
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
Grant 9,133,171 - Lucking , et al. September 15, 2
2015-09-15
Disubstituted 5-fluoro-pyrimidines
Grant 9,108,926 - Lucking , et al. August 18, 2
2015-08-18
17-(1'propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
Grant 9,034,856 - Klar , et al. May 19, 2
2015-05-19
19-nor-steroid derivatives with a 15.alpha.,16.alpha.-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives
Grant 8,987,239 - Klar , et al. March 24, 2
2015-03-24
6,7-Dihydro-5H-benzo[7]annulene derivatives, processes for their preparation, pharmaceutical products comprising them and their use for preparing medicaments
App 20150080438 - Wintermantel; Tim ;   et al.
2015-03-19
17-hydroxy-19-nor-21-carboxylic acid-steroid .gamma.-lactone derivative, use thereof, and medicament containing the derivative
Grant 8,937,058 - Klar , et al. January 20, 2
2015-01-20
Disubstituted 5-fluoro Pyrimidine Derivatives Containing A Sulfoximine Group
App 20150005329 - Lucking; Ulrich ;   et al.
2015-01-01
Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines
Grant 8,916,557 - Lucking , et al. December 23, 2
2014-12-23
4-aryl-n-phenyl-1,3,5-triazin-2-amines Containing A Sulfoximine Group
App 20140315906 - Lucking; Ulrich ;   et al.
2014-10-23
18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17b-carbolactones, Pharmaceutical Preparations Comprising Said Compounds And Use Thereof In The Treatment Of Endometriosis
App 20140288035 - Hubner; Jan ;   et al.
2014-09-25
Disubstituted 5-fluoro-pyrimidines
App 20140228387 - Lucking; Ulrich ;   et al.
2014-08-14
6 Substituted Imidazopyrazines For Use As Mps-1 And Tkk Inhibitors In The Treatment Of Hyperproliferative Disorders
App 20140187548 - Koppitz; Marcus ;   et al.
2014-07-03
6-substituted Imidazopyrazines For Use As Mps-1 And Tkk Inhibitors In The Treatment Of Hyperproliferative Disorders
App 20140135319 - Koppitz; Marcus ;   et al.
2014-05-15
Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
App 20140045852 - Lucking; Ulrich ;   et al.
2014-02-13
15, 16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
Grant 8,623,850 - Klar , et al. January 7, 2
2014-01-07
Substituted Imidazopyridazines
App 20130338133 - Klar; Ulrich ;   et al.
2013-12-19
Imidazopyrazines For Use As Mps-1 And Tkk Inhibitors In The Treatment Hyperproliferative Disorders
App 20130303532 - Koppitz; Marcus ;   et al.
2013-11-14
6-thio-substituted Imidazopyrazines For Use As Mps-1 And Tkk Inhibitors In The Treatment Of Hyperproliferative Disorders
App 20130281460 - Koppitz; Marcus ;   et al.
2013-10-24
Substituted 6-imidazopyrazines For Use As Mps-1 And Tkk Inhibitors In The Treatment Of Hyperproliferative Disorders
App 20130267527 - Koppitz; Marcus ;   et al.
2013-10-10
6,7-dihydro-5h-benzo[7]annulene Derivatives, Process For Preparation Thereof, Pharmaceutical Preparations Comprising Them, And The Use Thereof For Production Of Medicaments
App 20130252890 - Wintermantel; Tim ;   et al.
2013-09-26
Substituted Imidazopyrazines
App 20130210815 - Klar; Ulrich ;   et al.
2013-08-15
Imidazopyrazines
App 20130195848 - Klar; Ulrich ;   et al.
2013-08-01
18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
Grant 8,445,469 - Bohlmann , et al. May 21, 2
2013-05-21
19-NOR-STEROID DERIVATIVES WITH A 15a,16a-METHYLENE GROUP AND A SATURATED 17,17-SPIROLACTONE RING, USE THEREOF, AND MEDICAMENTS CONTAINING SAID DERIVATIVES
App 20130123219 - KLAR; Ulrich ;   et al.
2013-05-16
17.beta.-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative
Grant 8,207,150 - Kuhnke , et al. June 26, 2
2012-06-26
17Beta-Alkyl-17Alpha-oxy-estratrienes
App 20120157421 - Bohlmann; Rolf ;   et al.
2012-06-21
C-ring-substituted pregn-4-ene-21,17-carbolactones, and pharmaceutical preparations comprising the same
App 20110130371 - Ring; Sven ;   et al.
2011-06-02
Novel Anthranilamide Pyridinureas As Vascular Endothelial Growth Factor (vegf) Receptor Kinase Inhibitors
App 20110124680 - BOHLMANN; Rolf ;   et al.
2011-05-26
Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
Grant 7,906,533 - Bohlmann , et al. March 15, 2
2011-03-15
Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
Grant 7,902,229 - Bohlmann , et al. March 8, 2
2011-03-08
17-hydroxy-19-nor-21-carboxylic Acid-steroid Y-lactone Derivative, Use Thereof, And Medicament Containing The Derivative
App 20110021472 - Klar; Ulrich ;   et al.
2011-01-27
15,16-Methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid Y-lactone derivative, use thereof and medicinal products containing the derivative
App 20110015162 - Klar; Ulrich ;   et al.
2011-01-20
11b-fluoro-3-acetoxyestra-3,5-dien-17-one And Method For The Production Thereof
App 20110009654 - Petrov; Orlin ;   et al.
2011-01-13
15, 16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one Derivative , Use Thereof, And Medicament Containing Said Derivative
App 20110003779 - Klar; Ulrich ;   et al.
2011-01-06
17-(1'propenyl)-17-3'-oxidoestra-4-en-3-one Derivative, Use Thereof, And Medicament Containing Said Derivative
App 20100317632 - Klar; Ulrich ;   et al.
2010-12-16
19-nor-steroid Derivatives With A 15alpha, 16alpha-methylene Group And A Saturated 17, 17-spiro-lactone Ring, Use Thereof, And Medicaments Containing Said Derivatives
App 20100311702 - Klar; Ulrich ;   et al.
2010-12-09
18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same
Grant 7,846,917 - Bohlmann , et al. December 7, 2
2010-12-07
17beta-cyano-19-androst-4-ene Derivative, Its Use And Medicaments Comprising The Derivative
App 20100292184 - Kuhnke; Joachim ;   et al.
2010-11-18
Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
Grant 7,572,794 - Bohlmann , et al. August 11, 2
2009-08-11
17.alpha.-alkyl-17.beta.-oxy-estratrienes and intermediate products for their production, use of the 17.alpha.-alkyl-17.beta.-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
Grant 7,538,100 - Bohlmann , et al. May 26, 2
2009-05-26
Benzocycloheptene Derivatives As Estrogens Having Selective Activity
App 20090099250 - WYRWA; Ralf ;   et al.
2009-04-16
17Beta-CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE
App 20090048217 - KUHNKE; Joachim ;   et al.
2009-02-19
17Beta-CYANO-18A-HOMO-19-NOR-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE
App 20090048218 - KUHNKE; JOACHIM ;   et al.
2009-02-19
18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, As Well As Pharmaceutical Preparations That Contain The Latter
App 20090029953 - Bohlmann; Rolf ;   et al.
2009-01-29
Process For Preparing 17alpha-acetoxy-6-methylenepregn-4-ene-3,20-dione, Medroxyprogesterone Acetate And Megestrol Acetate
App 20090012321 - ANNEN; Klaus ;   et al.
2009-01-08
18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same
App 20080153787 - BOHLMANN; Rolf ;   et al.
2008-06-26
8.beta.-vinyl-11.beta.-(.omega.-substituted)alkyl-estra-1,3,5(10)-trienes
Grant 7,375,098 - Braeuer , et al. May 20, 2
2008-05-20
Androgenic 7-substituted 11-halogen steroids
Grant 7,361,645 - Bohlmann , et al. April 22, 2
2008-04-22
Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof
App 20070298456 - Zorn; Lud-wig ;   et al.
2007-12-27
Use of 8-Prenylnaringenin for Hormone Replacement Therapy
App 20070276032 - Huempel; Michael ;   et al.
2007-11-29
Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-Halogen steroids and uses thereof
Grant 7,262,023 - Zorn , et al. August 28, 2
2007-08-28
Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridones
App 20070135489 - Huth; Andreas ;   et al.
2007-06-14
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
Grant 7,202,260 - Huth , et al. April 10, 2
2007-04-10
Benzocycloheptenes, process for their production, pharmaceutical preparations that contain that latter as well as their use for the production of pharmaceutical agents
Grant 7,145,015 - Bohlmann , et al. December 5, 2
2006-12-05
Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
App 20060264425 - Bohlmann; Rolf ;   et al.
2006-11-23
18-Methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
App 20060252737 - Bohlmann; Rolf ;   et al.
2006-11-09
Novel nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
App 20060160861 - Bohlmann; Rolf ;   et al.
2006-07-20
Antiestrogens, process for their production and their pharmaceutical use
Grant 7,074,829 - Klar , et al. July 11, 2
2006-07-11
Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
App 20060116380 - Bohlmann; Rolf ;   et al.
2006-06-01
Composition containing an androgenous 11b-halogen steroid and a progestational hormone, and male contraceptive based on said composition
App 20060100180 - Nubbemeyer; Reinhard ;   et al.
2006-05-11
17.alpha.-ALKYL-17.beta.-OXY-ESTRATRIENES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, USE OF THE 17.alpha.-ALKYL-17.beta.-OXY-ESTRATRIENES FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS AS WELL AS PHARMACEUTICAL PREPARATIONS
Grant 7,018,994 - Bohlmann , et al. March 28, 2
2006-03-28
17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
App 20060009436 - Bohlmann; Rolf ;   et al.
2006-01-12
11.beta.-Substituted 19-nor-17-.alpha.-pregna-1,3,5(10)-trien-17.beta.-ols with a 21,16.alpha.-lactone ring
Grant 6,956,031 - Hillisch , et al. October 18, 2
2005-10-18
Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
App 20050182081 - Bohlmann, Rolf ;   et al.
2005-08-18
Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-halogen steroids that can be produced therefrom, their process for production and use as well as pharmaceutical prepartions that contain these compounds, as well as 7-substituted estra-1,3,5(10)-trie
App 20050090477 - Zorn, Ludwig ;   et al.
2005-04-28
Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
Grant 6,878,750 - Bohlmann , et al. April 12, 2
2005-04-12
Androgenic 7-substituted 11-halogen steroids
App 20050075322 - Bohlmann, Rolf ;   et al.
2005-04-07
8beta-Vinyl-11beta-(omega-substituted)alkyl-estra-1,3,5(10)-trienes
App 20050065135 - Braeuer, Nico ;   et al.
2005-03-24
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
App 20050049281 - Huth, Andreas ;   et al.
2005-03-03
11.beta. LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11.beta. LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS
Grant 6,790,842 - Bohlmann , et al. September 14, 2
2004-09-14
11.beta.-HALOGEN-7.alpha.-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11.beta.-HALOGEN-7.alpha.-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS
Grant 6,780,855 - Bohlmann , et al. August 24, 2
2004-08-24
11-Beta substituted 19-nor-17-alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring
App 20040014735 - Hillisch, Alexander ;   et al.
2004-01-22
17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
App 20030191099 - Bohlmann, Rolf ;   et al.
2003-10-09
New antiestrogens, process for their production and their pharmaceutical use
App 20030162830 - Klar, Ulrich ;   et al.
2003-08-28
11beta-halogen-7alpha-substituted Estratrienes, Metod For Producing Pharmaceutical Preparations Containing Said 11beta-halogen-7alpha- Substituted Estratrienes And Use Of The Same For Producing Medicaments
App 20030069434 - BOHLMANN, ROLF ;   et al.
2003-04-10
Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
App 20030050324 - Bohlmann, Rolf ;   et al.
2003-03-13
Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
Grant 6,495,607 - Bohlmann , et al. December 17, 2
2002-12-17
Benzocycloheptenes, Process For Their Production, Pharmaceutical Preparations That Contain The Latter As Well As Their Use For The Production Of Pharmaceutical Agents
App 20020068765 - BOHLMANN, ROLF ;   et al.
2002-06-06
7 .alpha.-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7 .alpha.(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents
Grant 6,288,051 - Bittler , et al. September 11, 2
2001-09-11
7.alpha.-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7.alpha.-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agents
Grant 6,271,403 - Bohlmann , et al. August 7, 2
2001-08-07
7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7.alpha.-(.xi.-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents
Grant 5,866,560 - Bohlmann , et al. February 2, 1
1999-02-02
Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents
Grant 5,807,899 - Bohlmann , et al. September 15, 1
1998-09-15
11.beta.-substituted 14,17-ethanoestratrienes, process for their production and their use as pharmaceutical agents
Grant 5,502,046 - Bohlmann , et al. March 26, 1
1996-03-26
N-substituted imidazoles, as well as their use in pharmaceutical agents
Grant 5,021,434 - Strehlke , et al. June 4, 1
1991-06-04
3-methylene-4-androsten-17-ones, process for their production and pharmaceutical preparations containing them
Grant 4,925,834 - Bohlmann , et al. May 15, 1
1990-05-15
N-substituted imidazoles as aromatase inhibitors
Grant 4,916,144 - Strehlke , et al. April 10, 1
1990-04-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed